Calkins Daniel sold VSTM
May 16, 2025 · Form 4 insider transaction
Calkins Daniel sold 38,850 shares of Verastem, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
38,850
Price
$0.00
Total value
N/A
InsiderCalkins Daniel
Role—
CompanyVerastem, Inc. (VSTM)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 16, 2025
Filing dateMay 20, 2025
Shares owned after125,198
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were subject to a performance RSU award that was granted on June 18, 2024. 150,000 RSUs vested on May 16, 2025, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria of approval by the FDA of an NDA for the Company's combination therapy of avutometinib and defactinib for the treatment of low-grade serous ovarian cancer had occurred.